From £6.99 per month
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares


Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Latest Views & News

Father Christmas

The annual Woodlarks Christmas Grotto appeal from Tom Winnifrith, 13% of the way there in 2 days - can you spare a tenner?

I know times are tough. But I am sure that if you are reading this you can afford a tenner or a fiver. And I ask that you hand that over to the amazing folks at Woodlarks as it does its first face to face Santa grottos for 200 kids whose, often short, lives are not like those we enjoy.

Tissue Regenix – “product launch” & “distribution agreement”, ramptastic?

Regenerative medical device company Tissue Regenix (TRX) states “following the successful launch of VNEW with ARMS Medical in September 2021, we are very pleased to be continuing our partnership and launching the VNEW Fascia Lata allograft for surgical procedures to support tissue”. So what of a share price response slightly lower to 0.575p?

Tom Winnifrith Bearcast: On Day 1 of the olive harvest, a challenge for loathsome Neill Ricketts but is he man enough?

It is day one of the harvest and feeling rather wet and very tired I explain a bit of what has gone on. Then it is onto Versarien (VRS), Chill Brands (CHLL) and musicMagpie (MMAG) two of which I expect to go bust in 2023.
Subscribe to ShareProphets to access Premium Content

Quiz plc – interims, still ‘very encouraging’ or not?

‘Occasion wear and dressy casual wear’ fashion company Quiz plc (QUIZ) has announced results for its half-year ended 30th September 2022, arguing its performance “reflecting the appeal of our differentiated and value brand”. So what of a currently edged up to 17p share price, above £21 million market cap?

Carclo – already anticipating ‘limited headroom on its interest cover covenant’, now a contract cancellation!

“Contract Cancellation” announcement from Carclo (CAR), which includes that the contract was “expected to deliver incremental sales of between £10m and £15m annually for the life of the contract with the board's most recent expectation being that production volumes would start building from the last quarter of the current financial year”. So what of a current share price response down approaching 9% at 13p, a £9.5 million market cap?

Zamaz – a deep dive into accounts reveals major issues

The year end accounts for Zamaz (ZAMZ) are now available so I have taken a look at the more detailed information and it just highlights just what a poor-quality business Zamaz is. I have grouped the findings under a number of themes.
Subscribe to ShareProphets to access Premium Content

Alpha Growth – buys another sub scale life insurance company: questions, questions

Another deal more questions. Alpha Growth (ALGW) announced the completion of its purchase of Old Mutual International (Guernsey) Ltd which was initially announced on 24 March 2022.
Subscribe to ShareProphets to access Premium Content

IXICO – “a strong set of financial results”, Really?

Medical analytics company IXICO plc (IXI) has announced what it emphasises as “a strong set of financial results… strong balance sheet supports the execution of our renewed five-year strategic plan”. So what of a share price response currently approaching 6% lower at 27.5p, to give a £13.2 million market cap?

The comedy continues at Moonpig Group

Before we get onto the continuing comedy at Moonpig (MOON), some good news out today for GSK (GSK) and Haleon (HLN) shareholders with some observations about the Zantac (ranitidine) litigation which has hassled both the latter two shares over the last few months.
Subscribe to ShareProphets to access Premium Content

Hiring Out Gear Is Ashtead's Game and it could Attract Big Business from a Beleaguered Building Trade

Hello Share Fans. Over the years the big tool-renter Ashtead Group (AHT) has been a big money spinner for me. Though a few years ago, I took the view that what goes up usually always comes down. So I sold the lot. Needless to say, that folly sparked yet another rally. I’m still shy of the shares, though. For the same reason: that good things don’t last forever. However, the firm’s latest numbers look to prove me wrong yet again.
Subscribe to our newsletter

Daily digest of our latest stories.

Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was